» Articles » PMID: 25880914

Identification of a Novel MicroRNA Signature Associated with Intrahepatic Cholangiocarcinoma (ICC) Patient Prognosis

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2015 Apr 17
PMID 25880914
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The clinical significance of microRNAs (miRNAs) in intrahepatic cholangiocarcinoma (ICC) is unclear. The objective of this study is to examine the miRNA expression profiles and identify a miRNA signature for the prognosis of ICC.

Methods: Using a custom microarray containing 1,094 probes, the miRNA expression profiles of 63 human ICCs and nine normal intrahepatic bile ducts (NIBD) were assessed. The miRNA signatures were established and their clinical significances in ICC were analyzed. The expression levels of some miRNAs were verified by quantitative real-time RT-PCR (qRT-PCR).

Results: Expression profile analysis showed 158 differentially expressed miRNAs between ICC and NIBD, with 77 up-regulated and 81 down-regulated miRNAs. From the 158 differentially expressed miRNAs, a 30-miRNA signature consisting of 10 up-regulated and 20 down-regulated miRNAs in ICC was established for distinguishing ICC from NIBD with 100% accuracy. A separate 3-miRNA signature was identified for predicting prognosis in ICC. Based on the 3-miRNA signature, a formula was constructed to compute a risk score for each patient. The patients with high-risk had significantly lower overall survival and disease-free survival than those with low-risk. The expression level of these three miRNAs detected by microarray was verified by qRT-PCR. Multivariate analysis indicated that the 3-miRNA signature was an independent prognostic predictor.

Conclusions: In this study, a 30-miRNA signature for distinguishing ICC from NIBD, and a 3-miRNA signature for evaluating prognosis of ICC were established, which might be able to serve as biomarkers for prognosis of ICC. Further studies focusing on these miRNAs may shed light on the mechanisms associated with ICC pathogenesis and progression.

Citing Articles

Differential circulating miRNA profiles identified miR-423-5p, miR-93-5p, and miR-4532 as potential biomarkers for cholangiocarcinoma diagnosis.

Supradit K, Prasopdee S, Phanaksri T, Tangphatsornruang S, Pholhelm M, Yusuk S PeerJ. 2024; 12:e18367.

PMID: 39677943 PMC: 11639864. DOI: 10.7717/peerj.18367.


competitively Binds to G3BPs and Activates MTORC1 to Enhance HER2 Positive Breast Cancer Trastuzumab Tolerance.

He Y, Liu Y, Gong J, Yang F, Sun C, Yan X Int J Biol Sci. 2024; 20(10):3923-3941.

PMID: 39113695 PMC: 11302882. DOI: 10.7150/ijbs.87415.


TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p.

Louis C, Ferlier T, Leroux R, Pineau R, Desoteux M, Papoutsoglou P JHEP Rep. 2023; 5(12):100900.

PMID: 38023605 PMC: 10665948. DOI: 10.1016/j.jhepr.2023.100900.


Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

Bao F, Liu J, Chen H, Miao L, Xu Z, Zhang G Cancers (Basel). 2022; 14(16).

PMID: 36010914 PMC: 9406189. DOI: 10.3390/cancers14163921.


Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.

Pavicevic S, Reichelt S, Uluk D, Lurje I, Engelmann C, Modest D Cancers (Basel). 2022; 14(4).

PMID: 35205774 PMC: 8870611. DOI: 10.3390/cancers14041026.


References
1.
Chen M . Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol. 2000; 14(12):1144-9. DOI: 10.1046/j.1440-1746.1999.01983.x. View

2.
Liu N, Chen N, Cui R, Li W, Li Y, Wei R . Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012; 13(6):633-41. DOI: 10.1016/S1470-2045(12)70102-X. View

3.
Chen L, Yan H, Yang W, Hu L, Yu L, Liu Q . The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol. 2008; 50(2):358-69. DOI: 10.1016/j.jhep.2008.09.015. View

4.
Wei R, Huang G, Zhang M, Li B, Zhang H, Shi M . Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma. Clin Cancer Res. 2013; 19(17):4780-91. DOI: 10.1158/1078-0432.CCR-12-2728. View

5.
Wang H, Ach R, Curry B . Direct and sensitive miRNA profiling from low-input total RNA. RNA. 2006; 13(1):151-9. PMC: 1705746. DOI: 10.1261/rna.234507. View